Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 11651 [2013-03737]

Download as PDF Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices will be displayed on the table where individuals sign up to make public comments; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. (3) If an individual in making a statement reveals personal information (e.g., medical information) about themselves that information will not usually be redacted. The NIOSH Freedom of Information Act (FOIA) coordinator will, however, review such revelations in accordance with the FOIA and the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (4) All disclosures of information concerning third parties will be redacted. (5) If it comes to the attention of the DFO that an individual wishes to share information with the Board but objects to doing so in a public forum, the DFO will work with that individual, in accordance with the Federal Advisory Committee Act, to find a way that the Board can hear such comments. Contact Person for More Information: Theodore Katz, DFO, NIOSH, CDC, 1600 Clifton Road, MS E–20, Atlanta, GA 30333, telephone: (513) 533–6800, toll free: 1–800– CDC–INFO, email: dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: The purpose of the meeting is to discuss the potential for forming an infectious disease laboratory working group under the BSC, OID. The agenda and any supplemental material will be available at www.cdc.gov/oid/ BSC.html after March 1. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639–4461. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–03612 Filed 2–15–13; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) TKELLEY on DSK3SPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 3:00–4:00 p.m. Eastern Time, March 14, 2013. Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1–877–951– 7311 with a passcode of 6420598. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and 17:49 Feb 15, 2013 Jkt 229001 [FR Doc. 2013–03610 Filed 2–15–13; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors shall provide guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board shall provide guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board shall evaluate the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters To Be Discussed: NIOSH Director Update; Implementation of the National Academies Program Recommendations for Construction Safety and Health, Respiratory Disease Studies, and Traumatic Injury Prevention, Nanotechnology Research Strategic Plan, Influenza Research, Agriculture, Forestry, and Fishing Sector Update. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Roger Rosa, Ph.D., Designated Federal Officer, BSC, NIOSH, CDC, 395 E Street SW., Suite 9200, Patriots Plaza Building, Washington, DC 20201, telephone (202) 245– 0655, fax (202) 245–0664. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) BILLING CODE 4163–18–P VerDate Mar<15>2010 Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. 11651 [FR Doc. 2013–03737 Filed 2–15–13; 8:45 am] In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Dates: 8:30 a.m.–3:15 p.m., March 21, 2013. Place: Patriots Plaza I, 395 E Street SW., Room 9200, Washington, DC 20201. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. If you wish to attend in person, please contact NIOSH at (202) 245–0625 or (202) 245–0626 for information on building access. Teleconference is available toll-free; please dial (877) 328–2816, Participant Pass Code 6558291. Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, Agency Information Collection Activities; Proposed Collection; Comment Request; Manufactured Food Regulatory Program Standards PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 BILLING CODE 4163–19–P Food and Drug Administration [Docket No. FDA–2013–N–0115] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Page 11651]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Dates: 8:30 a.m.-3:15 p.m., March 21, 2013.
    Place: Patriots Plaza I, 395 E Street SW., Room 9200, 
Washington, DC 20201.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 50 people. If you wish 
to attend in person, please contact NIOSH at (202) 245-0625 or (202) 
245-0626 for information on building access. Teleconference is 
available toll-free; please dial (877) 328-2816, Participant Pass 
Code 6558291.
    Purpose: The Secretary, the Assistant Secretary for Health, and 
by delegation the Director, Centers for Disease Control and 
Prevention, are authorized under Sections 301 and 308 of the Public 
Health Service Act to conduct directly or by grants or contracts, 
research, experiments, and demonstrations relating to occupational 
safety and health and to mine health. The Board of Scientific 
Counselors shall provide guidance to the Director, National 
Institute for Occupational Safety and Health on research and 
prevention programs. Specifically, the Board shall provide guidance 
on the Institute's research activities related to developing and 
evaluating hypotheses, systematically documenting findings and 
disseminating results. The Board shall evaluate the degree to which 
the activities of the National Institute for Occupational Safety and 
Health: (1) Conform to appropriate scientific standards, (2) address 
current, relevant needs, and (3) produce intended results.
    Matters To Be Discussed: NIOSH Director Update; Implementation 
of the National Academies Program Recommendations for Construction 
Safety and Health, Respiratory Disease Studies, and Traumatic Injury 
Prevention, Nanotechnology Research Strategic Plan, Influenza 
Research, Agriculture, Forestry, and Fishing Sector Update.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Roger Rosa, Ph.D., 
Designated Federal Officer, BSC, NIOSH, CDC, 395 E Street SW., Suite 
9200, Patriots Plaza Building, Washington, DC 20201, telephone (202) 
245-0655, fax (202) 245-0664.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-03737 Filed 2-15-13; 8:45 am]
BILLING CODE 4163-19-P